You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Novel Dense Hollow Fiber for Blood Gas Exchange

    SBC: MEDARRAY INC            Topic: N/A

    DESCRIPTION (provided by applicant): MedArray has successfully developed under SBIR Phase I and II, a novel silicone membrane hollow fiber for use in blood oxygenators. Our patented silicone hollow fiber has great commercial potential for use in long term extracorporeal membrane oxygenation (ECMO) as well as routine cardiopulmonary bypass. Because ECMO can last more than 1 day, dense rather than ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  2. Pre-Clinical HPV16 Antiviral Compound Development

    SBC: NANOVIR, LLC.            Topic: N/A

    DESCRIPTION (provided by applicant): Human Papillomavirus (HPV) 16 is by far the major cause of cervical dysplasia and cancer, but no effective treatment for the virus is available or anticipated. Major CDC- and/or WHO-authored reviews and surveys of treat ments for women infected by HPV16 typically refer to follow up observation and surgical intervention as the only options available, and rarel ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  3. Pre-Clinical HPV16 Antiviral Compound Development

    SBC: NANOVIR, LLC.            Topic: N/A

    Location NANOVIR, LLC. 4717 CAMPUS DR, STE 1300 KALAMAZOO, MI 49008 United States 2R42AI062182-03A1 $2 942 780.00 2 008 Pre-Clinical HPV16 Antiviral Compound Development Department of Health and Human Services National Institutes of Health STTR N N N PHS2 ...

    STTR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  4. Development of Oncomine Professional as a Platform for Biopharmaceutical Research

    SBC: COMPENDIA BIOSCIENCE, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): DNA microarray studies, largely sponsored by the NIH and other granting agencies, have generated a wealth of data uncovering the complex gene expression patterns of cancer. Currently however, there is no unifying organizational or bioinformatics resource to integrate the myriad independent observations into a single, global, computable environment. Such a reso ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  5. Device for Promoting Survival of Congested Tissue Flaps

    SBC: SPECTROCON, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): New technology is needed for the treatment of venous congestion, a serious complication of reconstructive surgery. Currently, live leeches are used, but are psychologically traumatic to patients, and are often ineff

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  6. Minimally invasive microwave antennas for image-guided focal tumor ablation

    SBC: MICRABLATE, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): In 2008, an estimated 1.4 million new patients will be diagnosed with cancer and most will not be eligible for surgery or will fail traditional regimens such as chemotherapy and radiation. As an alternative, thermal tum or ablation aims to destroy tumors using energy delivered by percutaneous devices placed under imaging guidance. Microwave energy has many adva ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  7. Development of a Convenient, Automated, Objective Measure of Depression

    SBC: HEALTHCARE TECHNOLOGY SYSTEMS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Depression is a serious, debilitating disorder that affects millions of people, but treatment research is hampered by the limited reliability of current outcome measures that are often biased by a number of methodologic al and clinical factors. Such considerations resulted in the issuance of Program Announcement 06-016, Development of Biomarkers for Mental Hea ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  8. Novel Nitrogen Enriched Air for Fire Suppression

    SBC: COMPACT MEMBRANE SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The objective of this Compact Membrane Systems (CMS) program is to develop a new platform technology for fire suppression and fire prevention systems around membrane supplied nitrogen enriched air (NEA). The limitation that the atmospheres used in the fire suppression be breathable to occupants in the proximity of a fire is easily accomplished by CMS technolog ...

    SBIR Phase II 2008 Department of Health and Human ServicesCenters for Disease Control and Prevention
  9. Plant-Derived hepatitis B Vaccine from Biomanufacturing System to Clinical Trial

    SBC: QUANTUM TUBERS CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): The ability of plants to be used as factories for the production of biopharmaceuticals has the potential to dramatically cut costs of production of many current biotherapeutics and will encourage development of new drug s and vaccines that can be genetically inserted into the genome of certain plants. Production via plants by growing biomass from plants that ar ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  10. Cell-Based, Chronic Wound Gene Therapy for Older Adults

    SBC: Stratatech Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): To date no biological treatment options specifically targeting the proteolytic nature of chronic wounds have been developed and marketed. Chronic skin wounds constitute an important medical problem for the growing age d population. 18% of diabetic patients over the age of 65 suffer from chronic, non-healing foot ulcers, and it is estimated that over 50,000 lo ...

    STTR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government